NMC Issues Guidelines to Combat Fake Patient Practice in Medical Colleges During Inspections

NMC’s MARB Issues Strict Guidelines to Detect and Curb “Fake Patient” Practices in Medical Colleges

Overview and regulatory context

The Medical Assessment and Rating Board (MARB) of the National Medical Commission (NMC) has issued firm guidelines to identify and act against the practice of admitting “fake patients” in medical colleges. The guidance accompanies MARB’s invitation for applications related to the establishment of new medical colleges and proposals to increase undergraduate (MBBS) seats for the Academic Year 2026–2027. The instructions reiterate existing regulatory obligations under the Under-Graduate Medical Education Regulations (UGMSR 2023) and Post-Graduate Medical Education Regulations (PGMSR 2024), which require medical colleges to maintain a minimum clinical material and investigation workload—such as outpatient (OPD) attendance, inpatient (IPD) admissions, bed occupancy, and surgical caseload—to ensure adequate clinical training for medical students.

Why this matters for medical education and patient care

Clinical exposure is a cornerstone of medical training. The mandated minimum clinical workload exists to ensure trainees gain hands-on experience in diagnosis, investigation, and inpatient management. When institutions artificially inflate inpatient numbers by admitting persons who do not require inpatient care, the integrity of clinical education and the quality of healthcare delivery are both compromised. MARB’s guidance emphasizes that the presence of fake patients undermines the educational environment and violates regulatory expectations intended to protect students, patients, and public health standards.

What MARB has observed and how it defines “fake patient practice”

MARB’s notice states that certain colleges have admitted persons who do not require treatment or inpatient management solely to meet occupancy or investigation metrics. During inspections, assessors who find evidence of such admissions must treat those findings as “fake patient practice.” This is categorized as a serious violation and will be addressed under Chapter V (Sanctions and Penalty) of the Establishment and Assessment regulations (2023). MARB further clarifies that detection of fake patients in even one postgraduate (PG) specialty may create reasonable suspicion about practices in other specialties, and the final regulatory decision will reflect those broader concerns.

Clear indicators assessors should watch for

MARB has provided observable indicators to help assessors identify potential fake patient admissions during inspections. The following signals should prompt closer verification and documentation:
– A disproportionately large number of admissions on the day of inspection or the previous day.
– Admitted patients whose ailments are trivial or manageable entirely on an outpatient basis with oral medications.
– Admissions lacking evidence of diagnostic investigations (for example, absence of X‑ray, blood tests, imaging reports) either before or after admission.
– Admitted patients who do not receive any typical inpatient interventions—such as intravenous cannulation, injections, catheterization, or medication administration—that would ordinarily justify admission.
– In pediatric wards, multiple children appearing playful and well, without signs of significant illness requiring inpatient care.
– Multiple admissions from the same family where clinical justification is not evident.
– A surge of admissions linked directly to preventive health checkups or screening camps, without subsequent inpatient treatment records.
– Any other assessor observations that reasonably indicate admissions were not clinically necessary.

Consequences, sanctions, and institutional impact

MARB has made it clear that detection of fake patient practice carries significant consequences. Possible actions include:
– Temporarily barring the institution from starting any new courses or from increasing intake in existing courses for a period to be specified by MARB.
– Impacting the renewal process for ongoing undergraduate and postgraduate courses.
– Imposition of penalties as outlined under Chapter V of the Establishment and Assessment and Rating Regulations (2023).

These measures are framed as necessary to safeguard training standards and to deter deliberate manipulation of clinical workload metrics. Importantly, a finding in a single PG specialty may lead MARB to take a view that encompasses all PG specialties within the institution, potentially magnifying regulatory consequences.

Inspection procedure and evidence collection

When an assessor suspects fake patient practice, MARB expects methodical documentation and evidence collection. The assessor should:
– Record admissions with timestamps and admission notes, highlighting any clustering on inspection dates.
– Verify the presence or absence of investigation reports (laboratory/imaging) associated with admitted patients.
– Check inpatient treatment records for documentation of procedures consistent with admission (e.g., IV lines, injections, catheterization, medications administered).
– Note clinical observations in pediatric and other wards that indicate the absence of significant illness.
– Corroborate whether admissions are linked to camps or preventive screenings without subsequent inpatient management.
– Compile any other relevant records or observations that substantiate the assessment.

MARB indicates that assessors may document suspected cases in a prescribed format and collect supporting documentary evidence to inform MARB’s final decision-making.

Implications for institutions and recommended actions

Medical colleges and institutions should proactively review admissions and inpatient management practices to ensure compliance with UGMSR 2023 and PGMSR 2024. Recommended institutional actions include auditing recent admissions for clinical justification, ensuring accurate documentation of investigations and inpatient treatments, and strengthening internal oversight to prevent manipulation of clinical statistics. Transparent record‑keeping and adherence to clinical governance principles will help institutions demonstrate compliance during MARB inspections.

Conclusion

MARB’s directive underscores regulatory commitment to preserving the integrity of clinical training and healthcare delivery. By enumerating clear indicators of fake patient practice and outlining potential sanctions, the Board reinforces that artificial inflation of clinical metrics will be treated as a serious violation. Institutions should respond through diligent record keeping, strict adherence to admission criteria, and internal audits to avoid penalties and protect educational standards. medichelpline will continue to report developments as institutions and regulators implement these guidelines.